AposHealth
Mr. Ostro has over 15 years of progressive experience in audit and financial management of private and public companies, and a proven record in providing high quality financial management services to companies in various business cycles and sectors.
Previously, Mr. Ostro managed the valuation team of emerging market structured credit desk at Barclays Capital in London, UK, specializing in valuation and risk management of complex derivatives and structured financial products. Prior to that, he served as a Senior Associate in the audit division of PwC, Israel.
Mr. Ostro is a qualified certified public accountant in Israel and holds an MSc in Finance and Economics (with merit) form London School of Economics and a BSc in Economics and Accounting (with magna cum laude) from Tel-Aviv University.
This person is not in any offices
AposHealth
AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions. The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living.